Changes in Outpatient Services and Medication Use Following a Non-fatal Opioid Overdose in the West Virginia Medicaid Program

Published in: Journal of General Internal Medicine (2019). https://doi.org/10.1007/s11606-018-4817-8

Posted on RAND.org on March 12, 2019

by Neel Koyawala, Rachel Landis, Colleen L. Barry, Bradley D. Stein, Brendan Saloner

Read More

Access further information on this document at Springer US  

This article was published outside of RAND. The full text of the article can be found at the link above.

West Virginia leads the USA in opioid overdoses, with a rate more than three times the national average. Post-overdose medications for opioid use disorder (MOUD) are protective against future deaths, yet are infrequently prescribed. Mental health disorders increase opioid overdose risk. Given the substantial burden of psychiatric comorbidities among people who overdose, it is important to understand how both MOUD and treatment for co-occurring mental health conditions change following overdoses.

Research conducted by

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.